These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 10149121)
1. Thrombogenesis and thrombolysis in acute ischemic syndromes. Pathophysiological and pharmacological rationales for and limitations of thrombolytic, antithrombin, antiplatelet therapy and angioplasty. Myler RK; Bell W J Invasive Cardiol; 1991; 3(3):95-114. PubMed ID: 10149121 [No Abstract] [Full Text] [Related]
3. [Usefulness of combination therapy of hybrid thrombolysis followed by back-up percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction]. Mukawa H; Sone T; Tsuboi H; Kondo J; Kosokabe T; Uesugi M; Imai H J Cardiol; 2001 Apr; 37(4):181-9. PubMed ID: 11337927 [TBL] [Abstract][Full Text] [Related]
4. Pathophysiological basis of the treatment of ischemic heart disease. Condorelli M Ann Ital Med Int; 1990; 5(3 Pt 3):322-4. PubMed ID: 2081092 [TBL] [Abstract][Full Text] [Related]
5. [Interventional or conservative approaches in acute coronary syndromes]. Rapezzi C; Ortolani P; Branzi A Ital Heart J; 2000 Jun; 1 Suppl 2():78-82. PubMed ID: 10905133 [TBL] [Abstract][Full Text] [Related]
6. Direct versus indirect thrombin inhibition in percutaneous coronary intervention. Marmur JD J Invasive Cardiol; 2002 Apr; 14 Suppl B():8B-18B. PubMed ID: 11967386 [No Abstract] [Full Text] [Related]
7. Outcome after combined reperfusion therapy for acute myocardial infarction, combining pre-hospital thrombolysis with immediate percutaneous coronary intervention and stent. Loubeyre C; Lefèvre T; Louvard Y; Dumas P; Piéchaud JF; Lanore JJ; Angellier JF; Le Tarnec JY; Karrillon G; Margenet A; Pougès C; Morice MC Eur Heart J; 2001 Jul; 22(13):1128-35. PubMed ID: 11428853 [TBL] [Abstract][Full Text] [Related]
9. Comparison of combination therapy of adenosine and nitroprusside with adenosine[correction for adensosine] alone in the treatment of angiographic no-reflow phenomenon: does 1 plus 1 equal 11? Bailey SR Catheter Cardiovasc Interv; 2004 Apr; 61(4):492-3. PubMed ID: 15065144 [No Abstract] [Full Text] [Related]
10. What an interventional cardiologist should know about the pharmacological treatment of acute myocardial infarction. Verheugt FW Semin Interv Cardiol; 1999 Mar; 4(1):17-20. PubMed ID: 10406064 [TBL] [Abstract][Full Text] [Related]
11. [The choice between primary angioplasty and thrombolysis: is there any change after GUSTO-IIb?]. Fazzini PF G Ital Cardiol; 1997 Jan; 27(1):79-84. PubMed ID: 9244715 [No Abstract] [Full Text] [Related]
12. [Treatment and care of coronary artery syndrome in Finland]. Vikman S; Airaksinen J; Tierala I; Peuhkurinen K; Majamaa-Voltti K; Niemelä M; Tuunanen H; Niemelä K; Nieminen MS Duodecim; 2005; 121(7):753-9. PubMed ID: 15909962 [No Abstract] [Full Text] [Related]
13. [Acute myocardial infarct--primary angioplasty or thrombolysis?]. Kelm M; Strauer BE Internist (Berl); 2000 Dec; 41(12):1331-6, 1338-40, 1342-3. PubMed ID: 11189068 [No Abstract] [Full Text] [Related]
17. Acute coronary syndromes: new developments in pharmacological treatment strategies. Gylys K; Gold M Crit Care Nurse; 2000 Apr; Suppl():3-14; quiz 15-6. PubMed ID: 11876169 [No Abstract] [Full Text] [Related]
18. [Thrombolysis or percutaneous coronary intervention in acute myocardial infarct]. Mihatov S Acta Med Croatica; 2004; 58(2):139-42. PubMed ID: 15208800 [TBL] [Abstract][Full Text] [Related]
19. [The importance of the knowledge of acute coronary syndrome]. Horváth I; Cziráki A; Papp L Orv Hetil; 2005 May; 146(20 Suppl 2):1068-74. PubMed ID: 15945235 [TBL] [Abstract][Full Text] [Related]
20. Low-molecular-weight heparins and glycoprotein IIb/IIIa inhibitors with percutaneous coronary intervention in acute coronary syndromes. Shimpi RA J Invasive Cardiol; 2003 Aug; 15(8):460-5. PubMed ID: 12890880 [No Abstract] [Full Text] [Related] [Next] [New Search]